Ipamorelin is a synthetic growth hormone secretagogue and selective ghrelin receptor agonist widely studied in laboratory settings for its interaction with growth hormone signalling pathways. Its receptor selectivity has made it a key compound in endocrine research, particularly where growth hormone release, metabolic regulation and hormonal signalling mechanisms are being investigated. In controlled research environments, Ipamorelin is commonly used in studies exploring growth hormone secretagogue receptor (GHSR-1a) activation, endocrine function, peptide pharmacology, metabolic signalling and comparative receptor activity. Its well-characterised synthetic structure and high purity make it suitable for advanced in-vitro applications requiring consistency, analytical reliability and reproducible research outcomes.